Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-02 · accession 0000899243-22-016653 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-04 | 2022-05-02 | VRTX | Arbuckle Stuart A | EVP, COO | S - Sale | $263.98 | -306 | 64.8K | -0.5% | -$80.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-02 | S | D | 306 | $263.98 | 64,760 | D | — | — |